A
ABOS
Acumen Pharmaceuticals, Inc.
2.605
-0.045-1.70%Opening10:01 09/21 EDT
OPEN/PREV CLOSE2.040/2.040
TODAY RANGE2.015-2.160
VOL713.98K
MARKET CAP154.04M
52 WEEK RANGE1.500-3.600
AVG VOL (3M)428.01K
% TURNOVER0.92%
TURNOVER--
P/E (TTM)-1.3047
% RANGE7.11%
EPS(TTM)-1.6325
P/E(FORWARD)-1.4372
P/B2.690
BVPS0.7919
DIVIDEND--
P/S142.20
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP142.45M
SHARES OUTSTANDING72.32M
NEXT EARNINGS11/10-11/16
FREE FLOAT66.88M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·09/17 09:50
Analysts’ Top Healthcare Picks: Acumen Pharmaceuticals (ABOS), High Tide (HITI)
Dow Jones·09/16 17:30
Acumen Pharmaceuticals Price Target Maintained With a $8.00/Share by BTIG
Benzinga·09/16 17:20
BTIG Reiterates Buy on Acumen Pharmaceuticals, Maintains $8 Price Target
TipRanks·09/16 15:31
Acumen Highlights Anti-AβO Pipeline at Investor Day
Dow Jones·09/15 16:30
Acumen Pharmaceuticals Is Maintained at Buy by Citigroup
Dow Jones·09/15 16:30
Acumen Pharmaceuticals Price Target Raised to $5.00/Share From $4.00 by Citigroup
TipRanks·09/15 10:15
Citi ups Acumen target, opens ‘upside 90-day catalyst watch’
TipRanks·08/24 00:28
Acumen Pharmaceuticals Earnings Call: Science vs. Runway
TipRanks·08/13 15:46
Citi Remains a Buy on Acumen Pharmaceuticals (ABOS)
TipRanks·08/12 11:29
Acumen Pharmaceuticals Reports Q2 Results, Advances Alzheimer’s Programs
Seeking Alpha·08/12 11:13
Acumen Pharmaceuticals GAAP EPS of -$0.45 misses by $0.12
Dow Jones·08/12 11:05
*Acumen Pharmaceuticals 2Q Loss/Shr 45c >ABOS
Same Industry
Name/Symbol
Change%
Price